HCM Q1 2017 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$63M+21.1% YoY

Gross Profit

$3M4.4% margin

Operating Income

-$8M-12.7% margin

Net Income

$841,0001.3% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+13.5%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$8M

Stock-Based Comp.

$966,500

Balance Sheet

Total Assets

$345M

Total Liabilities

$133M

Stockholders' Equity

$189M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63M	$52M	+21.1%
Gross Profit	$3M	$1M	+97.8%
Operating Income	-$8M	-$8M	-0.7%
Net Income	$841,000	$268,500	+213.2%